A Study of rhuMAb VEGF (Bevacizumab) in Combination With Chemotherapy in Patients With Previously Treated Breast Cancer
Clinical trial NCT00109239 · COMPLETED
Trial details
- NCT number
- NCT00109239
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2000-11-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.